Both types of treatment are available at the Institute. The Institute is also undertaking the development of immunotherapy for ovarian cancer. The Institute just received permission to establish a facility for growing immune cells to be administered to patients. This facility will be among the first in the United States and will be the first in the Chicago area. The growth of many leukemias and cancers are dependent upon growth factor stimulation.
Many tumors require the production of new blood vessels to support their growth.